MediFind found 5 doctor with experience in Sclerosing Mesenteritis near Galveston, TX. Of these, 5 are Experienced.
Utmb Faculty Group Practice
Samuel Mathis is a primary care provider, practicing in Family Medicine in Galveston, Texas. Dr. Mathis is rated as an Experienced provider by MediFind in the treatment of Sclerosing Mesenteritis. His top areas of expertise are Sciatica, Scoliosis, Glucocorticoid-Remediable Aldosteronism, and Hypertension. Dr. Mathis is currently accepting new patients.
Utmb Faculty Group Practice
Joseph Shabot is a Gastroenterologist in Galveston, Texas. Dr. Shabot is rated as an Experienced provider by MediFind in the treatment of Sclerosing Mesenteritis. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Trichohepatoenteric Syndrome, Diarrhea, Colonoscopy, and Endoscopy.
Utmb Faculty Group Practice
Meryann Corzo is a primary care provider, practicing in Family Medicine in Galveston, Texas. Dr. Corzo has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Sclerosing Mesenteritis. Her top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Generalized Anxiety Disorder (GAD). Dr. Corzo is currently accepting new patients.
Utmb Faculty Group Practice
Brooke Corning is a Gastroenterologist in Galveston, Texas. Dr. Corning is rated as an Experienced provider by MediFind in the treatment of Sclerosing Mesenteritis. Her top areas of expertise are Hemorrhoids, Gastroesophageal Reflux Disease (GERD), Bowel Incontinence, Diarrhea, and Endoscopy.
Utmb Faculty Group Practice
Caryl Guillermo is a primary care provider, practicing in Family Medicine in Galveston, Texas. Dr. Guillermo is rated as an Experienced provider by MediFind in the treatment of Sclerosing Mesenteritis. Her top areas of expertise are Sitosterolemia, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Guillermo is currently accepting new patients.
Last Updated: 10/30/2025
